共 50 条
- [21] Clinical Outcomes of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Infections with Susceptibilities among Levofloxacin, Cefepime, and Carbapenems [J]. CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2018, 2018
- [22] Prior Carriage Predicts Intensive Care Unit Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2022, 106 (02): : 525 - 531
- [23] Outcome of Antimicrobial Therapy of Pediatric Urinary Tract Infections Caused by Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae [J]. INFECTION AND CHEMOTHERAPY, 2013, 45 (04): : 415 - 421
- [25] Vancomycin-Resistant Enterococci and Extended-Spectrum β-Lactamase-Producing Bacterial Colonization of the Cervix after Emergency Cerclage: Is It Safe? [J]. ANTIBIOTICS-BASEL, 2021, 10 (08):
- [26] Risk factors for bloodstream infections due to extended-spectrum β-lactamase producing Enterobacteriaceae in cancer patients [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2018, 12 (04): : 265 - 272
- [28] Modelling and Simulation of the Effect of Targeted Decolonisation on Incidence of Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bloodstream Infections in Haematological Patients [J]. Infectious Diseases and Therapy, 2022, 11 : 129 - 143